donation
To request Mental Health
Services or to access Mental
Health Crisis Services Call:
1-800-375-4357

Medical Disorders
Resources
Basic InformationLookupsLatest News
Delta Variant Convinced Many to Get Vaccinated: PollOver Half of American Children Have Detectable Lead Levels in Their BloodSmartphone Apps May Aid in Heart Attack RecoveryBetter Diet, More Exercise Equals Better Blood PressureIntermittent Fasting Can Cut Your Risk of Diabetes, Heart DiseaseMask Mandates in Schools Curb Infections, CDC Studies ShowPfizer to Ask FDA Soon for Approval of Its COVID Vaccine for Younger ChildrenYou Think You Had COVID Before: Are You Really Immune Now?Keep Your Kids Safe From COVID While Playing SportsAHA News: Women May Be More Willing Than Men to Donate OrgansDNA Sensor Can Spot When COVID Is ContagiousTrials Show COVID Vaccines Well Worth It for Cancer PatientsCDC Endorses Booster Shots for Millions of AmericansChildhood Trauma Linked With Higher Odds for Adult Neurological IllsCancer in Hispanics: Good News and BadFDA Approves Pfizer Booster Shots for Seniors, High-Risk AmericansU.S. to Buy 500 Million More COVID Vaccine Doses for Global DonationAntibodies to Early Strains of COVID May Not Fight New Variants: StudyPregnant Women Who Get COVID Vaccine Pass Antibodies to NewbornsCDC Expert Panel to Weigh In on Vaccine BoostersWhich Kids Are at Highest Risk From COVID?4 Out of 10 Adults With No Known Heart Disease Have Fatty Hearts: StudyBooster Dose of J&J COVID Vaccine Increases ImmunityPost-Stroke Rehab: There's a Sweet Spot in the TimingCommon Form of Liver Cancer on the Rise in Rural AmericaCOVID Has Killed More Americans Than the Spanish Flu Did in 1918Telemedicine Gets High Marks for Follow-Ups After SurgeryPandemic Tied to Declining Birth Rates for U.S., Much of EuropeReview of Booster Shots for Moderna, J&J Vaccines Just Weeks Away: FauciDelta Variant Now Fueling 99% of U.S. COVID CasesLower Dose of Pfizer COVID Vaccine Works Well in Young Children, Company SaysFDA Panel OKs Pfizer Booster Shot forĀ  People 65 or Older, But Not YoungerPfizer, Moderna Vaccines Still Offer Good Protection Against Severe COVID: StudyTrial Into Antioxidant for Parkinson's Disease Yields Disappointing ResultsIs Flu Ready for a Comeback? Get Your ShotDrug Might Stop Heart Trouble Linked to Sickle Cell AnemiaChild Obesity Rose Sharply During PandemicFDA Advisory Panel to Meet on COVID Booster ShotsStatin Cholesterol Drugs May Help Fight Ulcerative ColitisAHA News: Physical Activity Is Helpful After a Stroke, But How Much Is Healthy?Special 'Strategies' Can Help People With Parkinson's Walk, But Many Patients UnawareEven When Undergoing Treatment, People With MS Gain From COVID VaccinesNIH Spending Nearly $470 Million on Long-Haul COVID StudyHospitalizing the Unvaccinated Has Cost U.S. Nearly $6 BillionIn 16 States, 35% or More Residents Now Obese: CDCPet Store Puppies Passing Drug-Resistant Bacteria to PeopleIs a Combo COVID/Flu Shot on the Way?1 in 500 Americans Has Died From COVID-19Having Even a Cousin or Grandparent With Colon Cancer Raises Your Risk: StudyBlood Cancer Patients Could Benefit From COVID Booster Shot: Study
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Inhaled COVID Vaccine Shows Promise in Animal Trials

HealthDay News
by Robert Preidt
Updated: Jul 13th 2021

new article illustration

TUESDAY, July 13, 2021 (HealthDay News) -- Breathing in protection: Scientists say an experimental inhaled COVID-19 vaccine shows promise in animal tests.

"The currently available vaccines against COVID-19 are very successful, but the majority of the world's population is still unvaccinated and there is a critical need for more vaccines that are easy to use and effective at stopping disease and transmission," said study co-leader Dr. Paul McCray. He's professor of pediatrics-pulmonary medicine, microbiology and immunology at the University of Iowa, in Iowa City.

"If this new COVID-19 vaccine proves effective in people, it may help block SARS-CoV-2 transmission and help control the COVID-19 pandemic," McCray added in a university news release.

The single-dose inhaled vaccine is similar to those commonly used to protect people against seasonal flu. It uses a harmless parainfluenza virus 5 (PIV5) to deliver the SARS-CoV-2 spike protein into cells, to trigger an immune response against COVID-19 infection.

PIV5 is related to common cold viruses and easily infects people without causing significant illness, the researchers explained.

Importantly, the vaccine can be stored at normal refrigerator temperatures for up to at least three months, the study authors noted.

In mice, the vaccine prompted a localized immune response that involved antibodies and cellular immunity, and provided complete protection against deadly doses of SARS-CoV-2. In ferrets, the vaccine prevented infection and disease, and appeared to block transmission of the coronavirus from infected ferrets to unprotected and uninfected ferrets in the same cage.

However, animal research doesn't always pan out in humans.

The study was published July 2 in the journal Science Advances.

Study co-leader Biao He said, "We have been developing this vaccine platform for more than 20 years, and we began working on new vaccine formulations to combat COVID-19 during the early days of the pandemic." He is a professor in the University of Georgia's department of infectious diseases, College of Veterinary Medicine.

"Our preclinical data show that this vaccine not only protects against infection, but also significantly reduces the chances of transmission," he noted.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19 vaccines.

SOURCE: University of Iowa, news release, July 8, 2021